Background Therapeutic trials are now underway in genetic forms of frontotemporal dementia (FTD) but clinical outcome measures are limited. The two most commonly used measures, the Clinical Dementia Rating (CDR)+National Alzheimer's Disease Coordinating Center (NACC) Frontotemporal Lobar Degeneration (FTLD) and the FTD Rating Scale (FRS), have yet to be compared in detail in the genetic forms of FTD. Methods The CDR+NACC FTLD and FRS were assessed crosssectionally in 725 consecutively recruited participants from the Genetic FTD Initiative: 457 mutation carriers (77 microtubule-associated protein tau (MAPT), 187 GRN, 193 C9orf72) and 268 family members without mutations (non-carrier control group). 231 mutation carriers (51 MAPT, 92 GRN, 88 ...
BACKGROUND: Although social cognitive dysfunction is a major feature of frontotemporal dementia (FTD...
Frontotemporal dementia (FTD) is a group of neurodegenerative diseases including a wide range of cli...
Objective Sensitive cognitive markers are still needed for frontotemporal dementia (FTD). The Benso...
BACKGROUND: Therapeutic trials are now underway in genetic forms of frontotemporal dementia (FTD) bu...
International audienceBackground: Therapeutic trials are now underway in genetic forms of frontotemp...
Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal dementia (...
Importance: Behavioral disturbances are core features of frontotemporal dementia (FTD); however, sym...
Importance: Behavioral disturbances are core features of frontotemporal dementia (FTD); however, sym...
Objectives: The clinical heterogeneity of frontotemporal dementia (FTD) complicates identification o...
BACKGROUND: Although social cognitive dysfunction is a major feature of frontotemporal dementia (FTD...
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American A...
BACKGROUND: Although social cognitive dysfunction is a major feature of frontotemporal dementia (FTD...
Frontotemporal dementia (FTD) is a group of neurodegenerative diseases including a wide range of cli...
Objective Sensitive cognitive markers are still needed for frontotemporal dementia (FTD). The Benso...
BACKGROUND: Therapeutic trials are now underway in genetic forms of frontotemporal dementia (FTD) bu...
International audienceBackground: Therapeutic trials are now underway in genetic forms of frontotemp...
Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal dementia (...
Importance: Behavioral disturbances are core features of frontotemporal dementia (FTD); however, sym...
Importance: Behavioral disturbances are core features of frontotemporal dementia (FTD); however, sym...
Objectives: The clinical heterogeneity of frontotemporal dementia (FTD) complicates identification o...
BACKGROUND: Although social cognitive dysfunction is a major feature of frontotemporal dementia (FTD...
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American A...
BACKGROUND: Although social cognitive dysfunction is a major feature of frontotemporal dementia (FTD...
Frontotemporal dementia (FTD) is a group of neurodegenerative diseases including a wide range of cli...
Objective Sensitive cognitive markers are still needed for frontotemporal dementia (FTD). The Benso...